
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1081 | 1073 | 1008 | 978 | 1309 | - |
Fund Return | 8.05% | 7.29% | 0.8% | -0.73% | 5.54% | - |
Place in category | 169 | 198 | 383 | 368 | 258 | - |
% in Category | 40 | 49 | 92 | 95 | 74 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1637619120 | 631.05M | 2.05 | -5.16 | - | ||
LU1637618742 | 224.08M | -0.48 | -8.69 | - | ||
AlphaBalanced B I | 132.55M | 1.19 | 4.59 | 2.74 | ||
AlphaBalanced B II | 132.55M | 1.22 | 4.67 | 2.81 | ||
AlphaBalanced B III | 132.55M | 1.22 | 4.76 | 2.93 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Europe Growth Class F s | 773.81M | 6.40 | 2.24 | 7.41 | ||
DNCA Invest Europe Growth Class I s | 773.81M | 6.36 | 2.04 | 7.28 | ||
DNCA Invest Europe Growth Class A s | 773.81M | 6.19 | 0.99 | 6.28 | ||
DNCA Invest Europe Growth Class B s | 773.81M | 6.12 | 0.59 | 5.88 | ||
LU1330191385 | 739.23M | 7.77 | 10.43 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SAP | DE0007164600 | 7.38 | 231.200 | -3.24% | |
AstraZeneca | GB0009895292 | 5.13 | 10,808.0 | -5.13% | |
Richemont | CH0210483332 | 4.76 | 135.85 | -6.02% | |
London Stock Exchange | GB00B0SWJX34 | 4.71 | 11,145.0 | -5.67% | |
Novo Nordisk B | DK0062498333 | 4.62 | 432.0 | -5.45% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review